Amin Naseem 4
4 · Bellerophon Therapeutics, Inc. · Filed Jan 4, 2022
Insider Transaction Report
Form 4
Amin Naseem
Director
Transactions
- Award
Stock Options (right to buy)
2021-12-31$3.10/sh+8,671$26,880→ 23,809 totalExercise: $3.10From: 2022-12-31Exp: 2031-12-31→ Common Stock (8,671 underlying) - Award
Common Stock
2021-12-31+39,032→ 160,287 total
Footnotes (1)
- [F1]RSAs fully vested on grant date.